SCHEMBL4465128

SCHEMBL4465128

Cn1nccc1-c1ccc(Cl)c(C(=O)NC(O)C2CCCCCC2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.58
AKT1 P31749 10/20 0.43
BRD4 O60885 1/20 0.42
BRD3 Q15059 1/20 0.42
ABL1 P00519 1/20 0.40
CNR2 P34972 1/20 0.40
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38
PDK3 Q15120 1/20 0.38
PDK4 Q16654 1/20 0.38
AKT2 P31751 3/20 0.38
SGK1 O00141 2/20 0.38
RPS6KB1 P23443 2/20 0.38
PRKCQ Q04759 2/20 0.38
ROCK1 Q13464 2/20 0.38
RPS6KA1 Q15418 2/20 0.38
AKT3 Q9Y243 2/20 0.38
KMT2A Q03164 1/20 0.38
ROCK2 O75116 1/20 0.38
KLRK1 P26718 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4461796 0.88 P2RX7 (0.47) P2RX7CNR2KMT2A
SCHEMBL12483745 0.82 P2RX7 (0.39) P2RX7RPS6KA1KMT2A
SCHEMBL12483220 0.81 P2RX7 (0.38) P2RX7AKT1CNR2KMT2A
SCHEMBL4475495 0.80 P2RX7 (0.57) P2RX7CNR2
SCHEMBL4479948 0.79 CNR2 (0.42) P2RX7CNR2
SCHEMBL4460932 0.78 NPC1 (0.48) KMT2A
SCHEMBL4471082 0.76 P2RX7 (0.40) P2RX7
SCHEMBL4461695 0.76 P2RX7 (0.41) P2RX7CNR2
SCHEMBL4459127 0.76 P2RX7 (0.40) P2RX7CNR2
SCHEMBL4467451 0.76 P2RX7 (0.58) P2RX7CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1837330-B1 Benzamide inhibitors of the P2X7 receptor PFIZER PROD INC (US) 2012-10-24 EP claimed
EP-1837330-A1 Benzamide inhibitors of the P2X7 receptor Pfizer Products Inc. (US) 2007-09-26 EP claimed
US-20070142329-A1 Benzamide Inhibitors of the P2X7 Receptor PFIZER INC. 2007-06-21 US claimed
EP-1837330-B1 Benzamide inhibitors of the P2X7 receptor PFIZER PROD INC (US) 2012-10-24 EP disclosed
US-7553972-B2 Benzamide inhibitors of the P2X7 receptor PFIZER, INC. (US) 2009-06-30 US disclosed
EP-1837330-A1 Benzamide inhibitors of the P2X7 receptor Pfizer Products Inc. (US) 2007-09-26 EP disclosed
US-20070142329-A1 Benzamide Inhibitors of the P2X7 Receptor PFIZER INC. 2007-06-21 US disclosed
US-7186742-B2 Benzamide inhibitors of the P2X7 receptor PFIZER INC (US) 2007-03-06 US disclosed
EP-1626962-B1 BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR PFIZER PROD INC (US) 2007-02-28 EP disclosed
US-20050009900-A1 Benzamide inhibitors of the P2X7 receptor ZOETIS LLC 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142329-A1 Benzamide Inhibitors of the P2X7 Receptor IL1R1, P2RY1, P2RX1 P2RX7 7/4885AKT1 2653/4885BRD4 320/4885
US-20050009900-A1 Benzamide inhibitors of the P2X7 receptor IL1R1, P2RY1, P2RX1 P2RX7 7/4885AKT1 2653/4885BRD4 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.